Talal Aboud, MD
Neurology · Braselton, GANPI 1487018701
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,088, 8.7 times the $125 reported in 2020.
Across 151 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$617
- UCB, Inc.$310
- Amgen$269
- AstraZeneca$240
- EMD Serono, Inc.$216
- Pfizer$185
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,657100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $617 |
| UCB, Inc. | 10 | $310 |
| Amgen(2 entities) | 15 | $269 |
| AstraZeneca(2 entities) | 4 | $240 |
| EMD Serono, Inc. | 5 | $216 |
| Pfizer | 10 | $185 |
| Medtronic | 1 | $171 |
| Neurelis, Inc. | 6 | $161 |
| Novartis | 6 | $131 |
| Lilly USA, LLC | 6 | $125 |
| Eisai Inc. | 4 | $123 |
| Jazz Pharmaceuticals Inc. | 4 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| Octapharma USA, Inc. | 4 | $84 |
| Argenx US, Inc. | 3 | $81 |
| CSL Behring | 3 | $78 |
| Lundbeck LLC | 2 | $59 |
| SK Life Science, Inc. | 2 | $58 |
| Sanofi | 3 | $54 |
| Acadia Pharmaceuticals Inc | 2 | $53 |
| Johnson & Johnson | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| MDD US Operations, LLC | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| Vertex | 1 | $34 |
| Kyowa Kirin, Inc. | 2 | $34 |
| Springworks Therapeutics, Inc. | 1 | $33 |
| Globus Medical | 1 | $33 |
| GE HealthCare | 1 | $28 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| Tanabe Pharma America, Inc. | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Banner Life Sciences, LLC | 1 | $20 |
| Biogen | 1 | $19 |
| Boston Scientific | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINQ II$171
How this compares
$3,657 in reported general payments places this provider in the 60th percentile of 506 neurology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 45 | $3,846 |
| Levetiracetam | 95 | $2,102 |
| Carbamazepine ErCarbamazepine | 20 | $2,091 |
| Divalproex Sodium | 11 | $741 |
| Gabapentin | 38 | $673 |
| Propranolol Hcl ErPropranolol Hcl | 11 | $351 |
| Primidone | 17 | $292 |
| Donepezil Hcl | 37 | $234 |
| Nortriptyline Hcl | 12 | $112 |
| Lamotrigine | 12 | $98 |
| Memantine Hcl | 13 | $90 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 17 | $71 |
Paid to pharmacies, not to this prescriber.
Other neurology in Braselton
- Mitzi WilliamsSmyrna$1.4M
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- John MorganAugusta$715K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
- Douglas StuartAtlanta$493K
- Sudhir AthniMacon$432K
- Dinesh RajuLawrenceville$414K
- Victor RosenfeldSavannah$413K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.